產品描述: Tezacaftor (VX-661)是第二個F508del CFTR校正藥物,協助CFTR蛋白到達細胞表面。Phase 2。 |
靶點:
F508del-CFTR(Cell-free assay);CFTR;Autophagy |
細胞實驗:
Cell lines: Primary HBE cells Concentrations: 5 μM Incubation Time: 24 h Method: Cells were treated with indicated concentration of drug for 24 h. |
動物實驗:
Animal Models: Male FVB/n mice Dosages: 2 mg/kg Administration: i.p. |
溶解性:
Soluble in DMSO |
保存條件:
-20℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
1.921 ml |
9.606 ml |
19.212 ml |
5 mM |
0.384 ml |
1.921 ml |
3.842 ml |
10 mM |
0.192 ml |
0.961 ml |
1.921 ml |
50 mM |
0.038 ml |
0.192 ml |
0.384 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |